Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2016 Oct 17;84(11):3141–3151. doi: 10.1128/IAI.00430-16

Gene bb0318 Is Critical for the Oxidative Stress Response and Infectivity of Borrelia burgdorferi

Adrienne C Showman 1, George Aranjuez 1, Philip P Adams 1, Mollie W Jewett 1,
Editor: C R Roy2
PMCID: PMC5067747  PMID: 27550932

Abstract

A greater understanding of the molecular mechanisms that Borrelia burgdorferi uses to survive during mammalian infection is critical for the development of novel diagnostic and therapeutic tools to improve the clinical management of Lyme disease. By use of an in vivo expression technology (IVET)-based approach to identify B. burgdorferi genes expressed in vivo, we discovered the bb0318 gene, which is thought to encode the ATPase component of a putative riboflavin ABC transport system. Riboflavin is a critical metabolite enabling all organisms to maintain redox homeostasis. B. burgdorferi appears to lack the metabolic capacity for de novo synthesis of riboflavin and so likely relies on scavenging riboflavin from the host environment. In this study, we sought to investigate the role of bb0318 in B. burgdorferi pathogenesis. No in vitro growth defect was observed for the Δbb0318 clone. However, the mutant spirochetes displayed reduced levels of survival when exposed to exogenous hydrogen peroxide or murine macrophages. Spirochetes lacking bb0318 were found to have a 100-fold-higher 50% infectious dose than spirochetes containing bb0318. In addition, at a high inoculum dose, bb0318 was found to be important for effective spirochete dissemination to deep tissues for as long as 3 weeks postinoculation and to be critical for B. burgdorferi infection of mouse hearts. Together, these data implicate bb0318 in the oxidative stress response of B. burgdorferi and indicate the contribution of bb0318 to B. burgdorferi mammalian infectivity.

INTRODUCTION

Borrelia burgdorferi, the causative agent of Lyme disease, is an obligate pathogen, relying on both its tick vector and its mammalian host for many of its nutrients. With a genome of only 1.5 Mbp, B. burgdorferi has significantly limited metabolic and biosynthetic capabilities, lacking genes encoding enzymes for de novo synthesis of amino acids, nucleotides, vitamin cofactors, and fatty acids (13). Thus, B. burgdorferi maintains a host-dependent lifestyle, acquiring these metabolic and biosynthetic precursors from its host environments. The genome of B. burgdorferi contains at least 52 open reading frames (ORFs) that encode transport and binding proteins, for a recognized 37 transport systems (1, 4). The utilization of transport systems to obtain biomolecules as precursors for essential metabolic processes is likely critical to the survival of B. burgdorferi throughout its infectious life cycle. Indeed, a subset of B. burgdorferi nutrient uptake systems has been demonstrated to play important roles in spirochete survival in vivo (58). This finding, as well as the fact that this spirochete lacks classical virulence factors, suggests that the ability of B. burgdorferi to scavenge nutrients and metabolites is not only a survival mechanism but also a significant component of B. burgdorferi pathogenesis. This ability therefore presents a possible avenue for the development of novel therapeutics for Lyme disease.

B. burgdorferi experiences deleterious reactive oxygen species (ROS) throughout its enzootic cycle. In contrast to the mechanism for most bacteria, DNA is not the major target of ROS damage in B. burgdorferi, likely due to the lack of intracellular free iron to generate the harmful effects of the Fenton reaction (9, 10). Rather, the unsaturated fatty acids contained in the B. burgdorferi membranes have been shown to be a primary target of ROS, resulting in lipid peroxidation and a loss of membrane integrity (9).

The oxidative stress response is critical for B. burgdorferi pathogenesis (1117). BosR is a transcriptional regulator (12, 1724) that is required for optimal resistance to oxidative stress (25) and the production of oxidative stress proteins, including superoxide dismutase (SodA) and coenzyme A disulfide reductase (CoADR, encoded by the cdr gene) (12, 14, 17, 18, 2426). Spirochetes lacking bosR, sodA, or cdr are avirulent in mice (13, 14, 19, 20, 25). Studies on the role of SodA during infection have demonstrated that this protein is important for controlling the levels of oxidation of critical metabolic proteins, as well as the production of factors known to be critical for infection (27).

Our application of an in vivo expression technology (IVET)-based genetic screen to seek out transcriptionally active regions of the B. burgdorferi genome during murine infection identified the candidate in vivo-expressed gene bb0318 (28), which is annotated to encode the ATP-binding protein of an ABC-type sugar transport system (1). The bb0318 gene is located within a putative operon including genes bb0319 to bb0316 (1, 29) and possibly bb0321 and bb0322 (30, 31). Genes bb0319 to bb0316, but not bb0321 and bb0322, are conserved in Treponema pallidum and Treponema denticola, and the homologs have been shown to be cotranscribed in T. pallidum (29). Furthermore, purified, recombinant BB0319, TP0298, and TDE0951, the putative substrate binding proteins from the B. burgdorferi, T. pallidum, and T. denticola transport systems, respectively, have been demonstrated to bind riboflavin. These data suggest that genes bb0319 to bb0316 may encode a ligand binding-dependent ABC transport system for riboflavin uptake (29).

Riboflavin is the precursor molecule required for synthesis of the enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (32). The B. burgdorferi genome appears to lack the genes encoding the typical enzymes involved in the synthesis of riboflavin, FMN, and FAD (1). However, the concentration of FAD within B. burgdorferi has been found to be approximately 1 μM (33), and B. burgdorferi has putative flavoenzymes (13, 26), suggesting that the spirochete may possess mechanisms to transport and/or synthesize FMN and FAD. For instance, BB0812 is a putative flavoenzyme, annotated as a bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate-cysteine ligase involved in coenzyme A (CoA) biosynthesis (1, 34), and FAD is a predicted cofactor for B. burgdorferi CoADR (11, 13). Unlike Escherichia coli, which uses the low-molecular-weight thiol glutathione and glutathione reductase (GSH/Gor), B. burgdorferi does not produce GSH and lacks a Gor homolog (1, 11). Instead, B. burgdorferi produces the low-molecular-weight thiol CoA, and the CoA/CoADR redox system is predicted to serve as an important pathway for eliminating ROS in the spirochete (11, 13, 33). Moreover, not only has CoADR been proposed to contribute to thiol/disulfide homeostasis and intermediary metabolism (13), but the flavoenzyme has also been shown to be critical for B. burgdorferi resistance to oxidative stress and its survival in the enzootic cycle (13). The putative riboflavin transport system, encoded by bb0319 to bb0316, may therefore aid in the ability of B. burgdorferi to resist oxidative stress and to combat the host innate immune response during infection, as the first step in the synthesis of a cofactor critical to its low-molecular-weight thiol redox system.

To elucidate the role of bb0318 during murine infectivity, we generated a B. burgdorferi in-frame deletion mutant lacking this gene. We demonstrate that Δbb0318 mutant spirochetes have increased sensitivity to hydrogen peroxide and murine macrophages in vitro, are highly attenuated in their ability to infect mice, and fail to exhibit detectable bacterial loads in murine heart tissue. Together, these findings indicate that bb0318 is important for B. burgdorferi infection of the mammalian host and suggest that the proposed nutrient uptake function of the BB0319-to-BB0316 ABC transport system is critical for B. burgdorferi pathogenesis.

MATERIALS AND METHODS

Bacterial clones and growth conditions.

All B. burgdorferi clones were derived from the low-passage-number infectious clone B31 A3. B31 A3-68Δbbe02 lacks plasmids cp9 and lp56, as well as the bbe02 gene on lp25 (35). B. burgdorferi cultures were grown in liquid Barbour-Stoenner-Kelly II (BSKII) medium containing gelatin and 6% rabbit serum at 35°C. Individual colonies were isolated by plating on solid BSK medium as described previously (36, 37) and were grown at 35°C under 2.5% CO2. B. burgdorferi cultures were grown in the presence of kanamycin (200 μg/ml), streptomycin (50 μg/ml), and/or gentamicin (40 μg/ml), as appropriate. Cloning steps were performed using Escherichia coli DH5α, grown in lysogeny broth (LB) or on LB agar plates. For E. coli cultures, kanamycin was used in at 50 μg/ml, spectinomycin at 300 μg/ml, and/or gentamicin at 10 μg/ml, as appropriate.

Generation of an in-frame deletion of bb0318 and the genetic complement.

The bb0318 deletion construct was engineered for in-frame replacement of the bb0318 open reading frame with the promoterless spectinomycin/streptomycin resistance gene aadA by the PCR-based overlap extension strategy described previously (28) using primers 1825, 1826, and 2084 to 2087 (Table 1). The allelic exchange plasmid pCR-BLUNT-Δbb0318-aadA was verified by PCR, restriction enzyme digestion, and DNA sequence analysis. B. burgdorferi A3-68Δbbe02 was transformed with 20 μg of pCR-Blunt-Δbb0318-aadA purified from E. coli as described previously (38). Streptomycin-resistant colonies were confirmed to be true transformants by PCR using primer pairs 1825–1826 and 2084–2085 (Table 1). Positive Δbb0318-aadA clones were screened with a panel of primers (39) for the presence of all of the B. burgdorferi plasmids of the parent A3-68Δbbe02 clone (35), and a single clone was selected for further experiments.

TABLE 1.

Primers and probes used in this study

Primer or probe no. Designation Sequence (5′–3′)a
Primers
    2084 BB0318 +500 5′ TATTGCTTAATATTTCAAGCTGAAGACC
    2085 BB0318 −500 3′ TTAAATCTGGCTTTGGAAATGCTG
    1825 aadA 5′ FWD ATGAGGGAAGCGGTGATCGCCGAAG
    1826 aadA 3′ RVS TTATTTGCCGACTACCTTGGTGATCTCGCCTT
    2086 BB0318 +500 3′ in frame GGCGAGATCACCAAGGTAGTCGGCAAATGATCTTTTTTAGAAATAGCTTTATG
    2087 BB0318 −500 5′ in frame CTTCGGCGATCACCGCTTCCCTCATTAATTTTGTTCCAAATTAATTTTTATACC
    2088 BB0318 comp fwd KpnI GGTACCGCTTTGGTAATACTTCCTATTG
    2089 BB0318 comp rvs SalI GTCGACTCATAAAAATAGCAATTCCTTTAATTTTTC
    1230 BB0318 FWD qPCR assay CAGATATTGACAAGCCTATTTG
    1231 BB0318 REV qPCR assay CCTCATCAAATTCAATAAGTCC
    1123 recA FWD AATAAGGATGAGGATTGGTG
    1124 recA RVS GAACCTCAAGTCTAAGAGATG
    1202 BB0319 inter 5′ CCGGGAATAAATAAAGCAATATTG
    1203 BB0319 inter 3′ AGGGTTTTGGATTTTATTTACG
    1196 BB0317 inter 5′ CTAAAAATGCCCCAAAATAAATCTG
    1197 BB0317 inter 3′ TTATATTAAAATGATATCTTGGCGC
    1192 BB0316 inter 5′ CGTTGATTAAGAGAAAAGATAGATC
    1193 BB0316 inter 3′ GTTGACATAAAAATTCCATATCCC
    1137 flaB-TaqMan-FWD TCTTTTCTCTGGTGAGGGAGCT
    1138 flaB-TaqMan-REV TCCTTCCTGTTGAACACCCTCT
    1140 nid-TaqMan-FWD CACCCAGCTTCGGCTCAGTA
    1141 nid-TaqMan-REV TCCCCAGGCCATCGGT
    1037 pUC18F CCCAGTCACGACGTTGTAAAAC
    1668 pUC18R AGCGGATAACAATTTCACACAG
Probes
    1139 flaB-TaqMan-Probe 6-FAM-AAACTGCTCAGGCTGCACCGGTTC-TAMRA
    1142 nid-TaqMan-Probe 6-FAM-CGCCTTTCCTGGCTGACTTGGACA-TAMRA
a

6-FAM, 6-carboxyfluorescein; TAMRA, 6-carboxytetramethylrhodamine.

The Δbb0318 clone was complemented in trans using the B. burgdorferi shuttle vector pBSV2G (40). A DNA fragment containing the bb0318 gene and an additional 362 bp of upstream sequence containing the putative endogenous promoter was amplified from B31 A3 genomic DNA using the Phusion enzyme (Thermo Scientific) and primers 2088 and 2089. When amplified, these primers introduced a KpnI restriction enzyme site at the 5′ end, and a SalI site at the 3′ end, of the PCR product. Following digestion with KpnI and SalI, pBSV2G was ligated with the DNA fragment and transformed into E. coli. The pBSV2G bb0318 plasmid structure and the presence of the DNA fragment were verified by PCR, restriction enzyme digestion, and DNA sequence analysis. Δbb0318-aadA spirochetes were then transformed with 20 μg pBSV2G bb0318 or pBSV2G alone, and positive transformants were selected as described previously (38). The clones that retained the B. burgdorferi plasmid content of the parent clone were selected for use in further experiments.

In vitro growth analysis.

Wild-type (A3-68ΔBBE02), Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes were inoculated in triplicate cultures at a starting density of 1 × 105 spirochetes/ml in 5 ml of BSKII medium containing the appropriate antibiotics. Spirochete densities were determined every 24 h by cell enumeration under dark-field microscopy using a Petroff-Hausser chamber over a 144-h period.

RNA isolation.

Biological triplicate cultures of wild-type (A3-68Δbbe02), Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes were grown to log phase (3 × 107 to 6 × 107 cells/ml) in 45 ml of BSKII medium. Cells were pelleted by centrifugation at 3,210 × g for 15 min. Pellets were snap-frozen in liquid nitrogen and resuspended in 640 μl of TE buffer (10 mM Tris, 1 mM EDTA [pH 8]) containing 0.5 mg/ml lysozyme and 1% SDS. RNA was isolated by hot phenol-chloroform extraction and ethanol precipitation as described previously (41). Samples were resuspended in diethyl pyrocarbonate (DEPC)-treated distilled water (dH2O). Contaminating DNA was removed using recombinant DNase I (Roche) in a 50-μl reaction mixture containing as much as 50 μg of RNA, 10 U of DNase I, ∼60 U of recombinant rRNasin (Promega), and 5 μl of 10× incubation buffer (Roche), incubated at 37°C for 15 min. DNase I treatment was followed by phenol-chloroform extraction and ethanol precipitation as described above.

Gene expression analysis.

cDNA was synthesized from 500 ng of RNA isolated from in vitro-grown spirochetes using the iScript Select cDNA synthesis kit and random hexamers (Bio-Rad), according to the manufacturer's instructions. Parallel cDNA reactions were carried out in the absence of reverse transcriptase (RT). One hundred nanograms of cDNA was used as the template in subsequent real-time quantitative PCRs (qPCRs). qPCR was performed using iQ SYBR green supermix and the following primer pairs: 1202 and 1203 (bb0319), 1230 and 1231 (bb0318), 1196 and 1197 (bb0317), 1192 and 1193 (bb0316), and 1123 and 1124 (recA). The amounts of bb0319, bb0318, bb0317, bb0316, and recA transcripts were determined using a genomic DNA standard curve for each gene target with 10 ng, 1 ng, 0.1 ng, and 0.01 ng of DNA. Both standard-curve reactions and PCRs using cDNA for each biological triplicate were performed in technical triplicate. mRNA transcript copy numbers for bb0319, bb0318, bb0317, and bb0316 were normalized to recA copies. All data sets were compared using one-way analysis of variance (ANOVA) followed by Tukey's posttest (GraphPad Prism, version 6.0).

H2O2 susceptibility assays.

Wild-type (A3-68Δbbe02), Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 clones were grown to mid-log phase (5 × 107 spirochetes/ml) in BSKII medium with the appropriate antibiotics. The spirochetes were washed twice in HN buffer (50 mM HEPES, 50 mM NaCl [pH 7.6]) and were resuspended in modified BSKII medium without sodium pyruvate (42) to a density of 1 × 104 spirochetes/ml. Reaction mixtures containing 1 × 104 spirochetes and either no hydrogen peroxide or 10 mM, 15 mM, or 20 mM hydrogen peroxide were incubated for 2 h at 35°C under 2.5% CO2. Serial dilutions were plated for CFU on solid BSK plating medium (36, 37). The percentage of survival was calculated by dividing the CFU under each H2O2 condition by the CFU in the absence of H2O2 and multiplying by 100. All experiments were performed at least three times. All data sets were compared using one-way ANOVA followed by Tukey's posttest (GraphPad Prism, version 6.0).

Macrophage killing assays.

Mouse-derived J774 macrophages were grown in Dulbecco's modified Eagle medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals) and 2 mM l-glutamine (Gibco) at 37°C under 5% CO2. Approximately 5 × 103 macrophages were seeded in 96-well tissue culture plates and were allowed to settle and attach for 24 h. Wild-type (A3-68Δbbe02), Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 clones were grown to mid-log phase (5 × 107 spirochetes/ml) in BSKII medium with the appropriate antibiotics. A total of 5 × 104 spirochetes per clone were added to wells containing 100 μl of DMEM plus FBS and l-glutamine with or without preseeded J774 macrophages. The plates were gently centrifuged at 50 × g for 5 min and were incubated at 37°C under 5% CO2 for 4 h (14). B. burgdorferi CFU counts were determined by plating the sample supernatants on solid BSK medium. The percentage of survival for each clone was calculated by dividing the CFU in the presence of macrophages by the CFU in medium alone and multiplying by 100. All experiments were performed in at least biological triplicate. All data sets were compared using one-way ANOVA followed by Tukey's posttest (GraphPad Prism, version 6.0).

Mouse infection experiments.

The University of Central Florida (UCF) is accredited by the International Association for Assessment and Accreditation of Laboratory Animal Care, and all experiments were approved by the Institutional Animal Care and Use Committee of UCF. All spirochetes used for mouse infection studies were grown to the same stationary-phase density (∼1 × 108/ml) in BSKII medium and were then diluted to the desired inoculum density just prior to use. All inoculum densities were determined using a Petroff-Hausser counting chamber and were verified by CFU counts on solid BSK medium. All inoculum cultures were analyzed for the endogenous plasmid content by PCR, and individual colonies from each population were analyzed for the presence of virulence plasmids lp25, lp28-1, and lp36 (43). All inoculum cultures carried the expected endogenous plasmid content, and 80 to 100% of individual colonies from each clone were confirmed to contain all three virulence plasmids. For the 50% infectious dose (ID50) analysis, groups of six 6- to 8-week-old female C3H/HeN mice (Envigo) were needle inoculated intraperitoneally (80% dose) and subcutaneously (20% dose) with 10-fold increasing doses as follows: A3-68Δbbe02 (wild-type), 1 × 103 to 1 × 105 spirochetes; Δbb0318/pBSV2G, 1 × 104 to 1 × 107 spirochetes; Δbb0318/pBSV2G bb0318, 1 × 103 to 1 × 105 spirochetes. The 50% infectious dose for each clone and associated 90% confidence intervals were calculated using probit regression analysis (JMP, version 12.2.0; SAS Institute, Inc.). For single-dose infection studies, groups of six 6- to 8-week-old female C3H/HeN mice (Envigo) were needle inoculated intraperitoneally (80%) and subcutaneously (20%) with 1 × 107 A3-68Δbbe02 (wild-type), Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes. Unless specified otherwise, mouse infection was assessed 3 weeks postinoculation by serology and/or reisolation of spirochetes from ear, bladder, and joint tissues, as described previously (6). A mouse was considered infected if spirochetes were reisolated from at least one of the three tissues analyzed.

Quantification of spirochete loads in mouse tissues.

Ear, heart, and joint tissues were collected from mice 1, 2, or 3 weeks after inoculation with B. burgdorferi, and DNA was extracted as described previously (44). Spirochete loads in mouse tissues were then determined by qPCR and a standard-curve approach as described above, using 100 ng of DNA extracted from mouse tissues as the template. The number of B. burgdorferi genomes was determined using flaB TaqMan primers and probe (primers 1137 and 1138; probe 1139), and the number of mouse genomes was determined using nid TaqMan primers and probe (primers 1140 and 1141; probe 1142). Each tissue sample was analyzed in triplicate qPCRs, and data are reported as the number of flaB copies per 1010 nid copies. All data sets were compared using one-way ANOVA followed by Tukey's posttest (GraphPad Prism, version 6.0).

RESULTS

Spirochetes lacking bb0318 are not defective for in vitro growth.

Gene bb0318 is located on the B. burgdorferi chromosome within a predicted operon comprised of genes bb0319 to bb0316 (1, 29) and possibly bb0321 and bb0322 (30, 31). Genes bb0319 to bb0316 are tightly organized in the genome, with no nucleotides separating the adjacent open reading frames (1). Genes bb0319 and bb0321 are separated by 180 bp, and genes bb0321 and bb0322 are separated by 32 bp (1). Genes bb0321 and bb0322 share no sequence identity with the genes upstream of the bb0319-to-bb0316 homologs in T. pallidum. Gene bb0318 was previously identified as a candidate gene expressed during murine infection (28). Quantitative reverse transcriptase PCR (qRT-PCR) analysis of RNA isolated from B. burgdorferi-infected unfed nymphs, fed nymphs, and mouse tissues indicated that the bb0318 gene is expressed not only during murine infection but throughout the B. burgdorferi tick-mouse infectious cycle (see Fig. S1 in the supplemental material). Furthermore, the transcript levels detected for genes bb0319, bb0318, bb0317, and bb0316 were distinct from one another within each of the three biologically relevant environments (Fig. S1). However, these data are unable to distinguish between differential expression of monocistronic transcripts and differential detection of each individual gene in a polycistronic operon due to RNA degradation.

To generate a bb0318 mutant while avoiding polar effects on the surrounding genes, the entire BB0318 open reading frame was replaced in frame with the promoterless aadA spectinomycin/streptomycin resistance gene by allelic exchange in a low-passage-number infectious derivative of B. burgdorferi strain B31 (Fig. 1A and B). Streptomycin-resistant clones lacking bb0318bb0318) were successfully recovered on solid BSK medium containing streptomycin, demonstrating that the aadA gene was expressed within the bb0319-to-bb0316 locus during in vitro growth. Complementation of bb0318 was accomplished through reintroduction of bb0318 along with 362 bp of additional upstream sequence on the B. burgdorferi shuttle vector pBSV2G (40) (Δbb0318/pBSV2G bb0318). Analysis by qRT-PCR measuring the transcript levels of bb0318 and the surrounding genes bb0319, bb0317, and bb0316 in the wild-type, Δbb0318, and Δbb0318/pBSV2G bb0318 clones demonstrated that in-frame deletion of bb0318 and its complementation in trans did not affect the expression of the adjacent genes (Fig. 1C). Expression of the bb0318 gene was restored in the complemented clone, but to a level below that of the wild type (Fig. 1C), suggesting that additional upstream regulatory sequence may be necessary to drive wild-type levels of bb0318 expression. However, bb0318 expression in the Δbb0318 mutant harboring a bb0318 complementation construct carrying 1,197 bp of upstream sequence, including bb0318, bb0319, and an additional 145 bp, demonstrated similar partial restoration (data not shown). Therefore, to avoid having both chromosomal and plasmid-encoded copies of bb0319, the Δbb0318 complement carrying only bb0318 and 362 bp of upstream sequence was selected for use in subsequent experiments. In vitro growth analysis of wild-type, Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes showed no difference in growth over a 144-h period (Fig. 1D), indicating that bb0318 is dispensable for spirochete growth in standard culture medium.

FIG 1.

FIG 1

The in-frame deletion of bb0318 is nonpolar and has no effect on spirochete growth in vitro. (A) Schematic representation of the wild-type (WT) and Δbb0318 loci on the chromosome. The sequence of the BB0318 open reading frame was replaced directly in frame with the aadA antibiotic resistance cassette in order to prevent a polar effect on the expression of the surrounding genes. Dashed lines mark deletion boundaries; primer numbers and small arrows indicate the locations of primers used to verify the mutant construct. (B) PCR analysis of the bb0318 mutant clone. Genomic DNAs from WT-background spirochetes and Δbb0318 spirochetes were used as the templates for PCR analyses (indicated above the gel). The primer pairs used to amplify specific DNA sequences correspond to the labels in panel A and are given beneath the gel. DNA ladder fragment sizes (in base pairs) are given on the left. (C) qRT-PCR analysis of genes surrounding bb0318 in mutant and complemented clones. Spirochete RNA was isolated from log-phase-grown WT, mutant, and complemented clones, and the expression of the recA, bb0319, bb0318, bb0317, and bb0316 genes was quantified by reverse transcriptase qPCR. The data are expressed as the number of mRNA transcripts per number of recA transcripts and are averages for three biological replicates. (D) Analysis of the growth of WT, Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes. Clones were grown in 5-ml biological triplicate cultures and were enumerated by dark-field microscopy every 24 h.

Spirochetes lacking bb0318 are more susceptible to ROS-mediated killing.

The BB0318 protein is the predicted ATPase component of a putative binding protein-dependent ABC transport system for riboflavin uptake (1, 29). Given that riboflavin is the precursor molecule for the synthesis of FMN and FAD, both of which are cofactors for flavoenzymes critical for the CoA/CoADR redox system, involved in resistance to oxidative stress (1, 11, 13, 26, 33), we hypothesized that Δbb0318 spirochetes might demonstrate increased susceptibility to reactive oxygen species (ROS). To test this hypothesis, the wild-type, Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 clones were grown under standard conditions and were then treated with various concentrations of hydrogen peroxide (H2O2) ranging from 10 to 20 mM. Minimal killing of wild-type, Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes was observed at a dose of 10 mM H2O2, with an average survival of approximately 80% for each clone (Fig. 2A). However, spirochetes lacking bb0318 were significantly more susceptible than wild-type spirochetes to 15 mM or 20 mM exogenous H2O2 (Fig. 2A). Although not statistically significant, the trend in the data suggested greater susceptibility of the Δbb0318/pBSV2G mutant than of the complemented clone to the 15 mM and 20 mM concentrations of H2O2 (Fig. 2A). There was no significant difference in susceptibility between the wild-type and bb0318 complemented clones at 15 mM exogenous H2O2; however, treatment with 20 mM exogenous H2O2 resulted in significantly more killing of bb0318 complemented spirochetes than of wild-type spirochetes.

FIG 2.

FIG 2

Δbb0318 spirochetes demonstrate sensitivity to H2O2 and murine macrophages. (A) A total of 1 × 104 mid-log-phase wild-type (WT), Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes were either left unexposed or exposed to 10 mM, 15 mM, or 20 mM exogenous H2O2. Following a 2-h incubation, spirochetes were serially diluted and were plated for CFU. (B) A total of 5 × 104 mid-log-phase WT, Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes were incubated in the presence or absence of J774 murine macrophages for 4 h. Spirochetes were serially diluted and were plated for CFU. The percentage of survival of each clone under each challenge condition was calculated by dividing the number of CFU in the presence of the challenge by the number of CFU for the matched medium-alone control, multiplying by 100, and subtracting from 100%. Data are averages ± standard deviations for at least three biological replicates for each clone and are plotted on a logarithmic scale. Data sets were compared across clones by use of one-way ANOVA and Tukey's posttest (GraphPad Prism, version 6.0). Statistical comparisons were not found to be significant unless otherwise noted. Asterisks indicate significant differences (P < 0.05) from wild-type and/or Δbb0318/pBSV2G bb0318 spirochetes.

To begin to understand the biological significance of the requirement for bb0318 for wild-type levels of resistance to ROS, we analyzed the abilities of the wild-type, Δbb0318/pBSV2G, and Δbb0318/pBSV2G bb0318 spirochetes to survive in the presence of murine macrophages, one of the major sources of ROS produced by the innate immune system of the mammalian host in response to B. burgdorferi infection (45). In agreement with our findings of increased susceptibility to H2O2, coincubation of spirochetes with murine macrophages resulted in a significantly lower percentage of survival of the Δbb0318 clone than of either the wild-type or the bb0318 complemented clone (Fig. 2B). Together, these results indicate that in the absence of bb0318, the ability of B. burgdorferi to respond to ROS stress conditions is attenuated.

The infectious dose of spirochetes lacking bb0318 is 100-fold greater than that of spirochetes containing bb0318.

In order to investigate the role of bb0318 during a mammalian infection, we were interested in quantifying the infectious capability of B. burgdorferi with and without bb0318. In groups of six, C3H/HeN mice were needle inoculated with 10-fold increasing doses of wild-type, Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes. Three weeks postinoculation, the 50% infectious dose (ID50) of each of these clones was determined on the basis of reisolation of spirochetes from ear, bladder, and joint tissues (Table 2). The ID50 value for Δbb0318/pBSV2G spirochetes was calculated by probit regression analysis to be 3.5 × 106 spirochetes. This dose was approximately 100-fold greater than the ID50 values calculated for the wild-type and Δbb0318/pBSV2G bb0318 spirochetes (3.6 × 104 and 4.8 × 104 spirochetes, respectively) (Fig. 3; Table 2). The ID50 values for the wild-type and Δbb0318/pBSV2G bb0318 spirochetes identified in this experiment are slightly higher than those reported previously for the B31 A3 genetic background (28, 44, 46, 47). Together, these data suggest that bb0318 promotes B. burgdorferi mammalian infectivity.

TABLE 2.

Spirochetes lacking bb0318 have a 100-fold-attenuated infectious dose

Clone genotype No. of mice infecteda/no. analyzed with the following spirochete dose:
ID50 (90% CI)c
1 × 103 1 × 104 1 × 105 1 × 106 1 × 107
Wild type 0/6 1/6 3/6 N/A N/A 3.6 × 104 (7.9 × 102–1.6 × 106)
Δbb0318/pBSV2G N/A 0/6 0/6 1/6b 5/6 3.5 × 106 (1.0 × 106–1.2 × 107)
Δbb0318/pBSV2G bb0318 0/6 1/6 4/6 N/A N/A 4.8 × 104 (2.1 × 103–1.0 × 106)
a

Mouse infection was determined 3 weeks postinoculation by positive reisolation of spirochetes from the ear, bladder, and joint tissues unless otherwise noted. N/A, not applicable.

b

Positive reisolation of spirochetes from bladder and joint tissues only.

c

The 50% infectious dose (ID50) is the number of spirochetes required to infect 50% of the mice inoculated. The ID50 values and associated 90% confidence intervals (90% CI) were calculated using probit regression analysis (JMP, version 12.2.0; SAS Institute, Inc.).

FIG 3.

FIG 3

The 50% infectious dose (ID50) of Δbb0318 spirochetes is 100-fold greater than those of wild-type and bb0318+ spirochetes. Groups of mice were inoculated intraperitoneally with various doses of wild-type (WT), Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes. Three weeks postinoculation, positive infection was determined based on spirochete reisolation from ear, bladder, and/or joint tissues. A mouse was considered infected if spirochetes were reisolated from at least one of the three tissues analyzed. The mouse infection data are presented in Table 3. Probit regression was used to plot the percentage of infected animals per group against the base 10 logarithm of the inoculum dose (log10 dose).

Spirochetes lacking bb0318 exhibit reduced bacterial loads in mouse heart tissue.

To further elucidate the infection phenotype of Δbb0318 spirochetes, we quantitated the spirochete loads in tissues from groups of six mice inoculated with wild-type, Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes at a dose of 1 × 107, the dose at which Δbb0318/ pBSV2G spirochetes are expected to infect the majority of mice tested (Table 2). All six mice inoculated with either wild-type or Δbb0318/pBSV2G bb0318 spirochetes were positive for infection as determined by reisolation of spirochetes from tissues and the presence of B. burgdorferi-specific antibodies (Table 3). Five of the six mice inoculated with Δbb0318/pBSV2G spirochetes were positive for infection by the same qualitative measures (Table 3). Total DNA was extracted from ear, heart, and joint tissues of the infected mice. Quantitative PCR (qPCR) performed using DNA from each tissue as the template measured the number of B. burgdorferi genomes, represented by flaB copies, and the number of mouse genomes, represented by nid copies. Interestingly, the average spirochete load quantified from heart tissues of mice infected with Δbb0318 spirochetes was significantly lower than those of mice infected with spirochetes containing bb0318 (Fig. 4A). In contrast, there was no significant difference in average spirochete loads measured in infected ear or joint tissues among all three clones (Fig. 4B and C). These data indicate not only that bb0318 may be necessary for B. burgdorferi to achieve a wild-type infectious dose but also that spirochetes lacking bb0318 may be dysfunctional in their ability to disseminate to and/or persist in the heart.

TABLE 3.

B. burgdorferi lacking bb0318 displays qualitative measures of infection at a dose of 1 × 107 spirochetes

Clone genotype No. of positive mice/no. of mice analyzed as determined by:
Serologya Reisolation of spirochetes from tissuesb
Ear Bladder Joint
Wild type 6/6 6/6 6/6 6/6
Δbb0318/pBSV2G 5/6 4/6 4/6 5/6
Δbb0318/pBSV2G bb0318 6/6 5/6 6/6 6/6
a

Determined 3 weeks postinoculation by serological response to B. burgdorferi proteins.

b

Assessed 3 weeks postinoculation. A mouse was considered infected if spirochetes were reisolated from at least one of the three tissues analyzed.

FIG 4.

FIG 4

Spirochetes lacking bb0318 exhibit reduced loads in heart tissue. Total DNA was isolated from spirochete-infected heart (A), ear (B), and joint (C) tissues harvested 3 weeks following the inoculation of mice with 1 × 107 wild-type (WT), Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes. Spirochete loads in tissues were quantified by qPCR, and the data are presented as the number of spirochete flaB copies per 1010 mouse nid copies. The mean for each group of data is represented by a horizontal line. Data sets were compared across clones by use of one-way ANOVA and Tukey's posttest (GraphPad Prism, version 6.0). Statistical comparisons were not found to be significant unless otherwise noted. Asterisks indicate significant differences (P < 0.05).

Spirochetes lacking bb0318 demonstrate delayed infection kinetics in mice.

As a means for gaining a better understanding of the possible dissemination defect of the Δbb0318 mutant clone, we performed a time course infection experiment. Groups of six mice each were infected with either wild-type, Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes at a dose of 1 × 107. At 1 week, 2 weeks, and 3 weeks postinoculation, groups of mice were assessed for infection by reisolation of spirochetes from tissues, followed by quantitation of spirochete loads in tissues. B. burgdorferi lacking bb0318 exhibited a marked delay in infection kinetics. Although 3 out of 6 mice were found to be infected with the mutant at week 1 as defined by reisolation of spirochetes from at least one tissue, spirochetes were reisolated from only 17% of the ear and bladder tissues and 33% of the joint tissues (Fig. 5A). In contrast, at the same time point, spirochetes were reisolated from 100% of all tissues analyzed for mice inoculated with wild-type spirochetes and from 50% of the ear tissues and 67% of the bladder and joint tissues for mice inoculated with Δbb0318/pBSV2G bb0318 spirochetes (Fig. 5A). Quantitative analysis of the spirochete loads in the ear, heart, and joint tissues of infected mice revealed the bacterial burdens of the Δbb0318 mutant and bb0318 complement clones in the ear tissues to be significantly lower than that of the wild-type clone at week 1 (Fig. 5B). Overall, little infection was detected in the heart and joint tissues for all clones at this early time point, resulting in no significant clone-specific differences in spirochete loads (Fig. 5B). The Δbb0318/pBSV2G spirochetes continued to demonstrate delayed dissemination to distal tissues at weeks 2 and 3 postinfection, with 50% and 83% of ear tissues and 33% and 67% of bladder and joint tissues positive for spirochete reisolation at the two time points, respectively (Fig. 5A). In contrast, wild-type and Δbb0318/pBSV2G bb0318 spirochetes were reisolated from 100% of the tissues analyzed at both weeks 2 and 3 (Fig. 5A). As was described for week 1, the bacterial burden of the Δbb0318 mutant in the ear tissues 2 weeks postinfection was significantly lower than that of the wild-type clone (Fig. 5C). There were no significant clone-specific differences between the spirochete loads in heart tissues at week 2, although the spirochete loads in the hearts at this time point suggested lower numbers of Δbb0318 spirochetes than of the clones carrying the bb0318 gene (Fig. 5C). The joint tissues from mice infected with the bb0318 complemented clone had bacterial burdens significantly different from the joint tissues of wild-type-infected mice at week 2, whereas the Δbb0318 clone-infected joints did not. By week 3, while the majority of mice inoculated with Δbb0318 spirochetes were positive for infection by reisolation (Fig. 5A), the spirochete loads measured in the heart tissues infected with the mutant were significantly lower than those for the wild-type and complemented clones, recapitulating the results shown in Fig. 4 (Fig. 5D). Together, these data indicate that spirochetes lacking bb0318 are attenuated in their ability to disseminate early during infection and are unable to establish an infection in heart tissue through 3 weeks postinfection.

FIG 5.

FIG 5

Spirochetes lacking bb0318 demonstrate delayed infection kinetics. Groups of mice were needle inoculated with 1 × 107 wild-type (WT), Δbb0318/pBSV2G, or Δbb0318/pBSV2G bb0318 spirochetes. (A) At 1, 2, or 3 weeks postinoculation, mice were analyzed for infection by reisolation of spirochetes from ear, bladder, and joint tissues. Data are represented as the percentage of each tissue type from each group of mice found to be positive for spirochete reisolation at each time point. (B through D) DNA was isolated only from the tissues of those mice found to be positive for infection, as defined by reisolation of spirochetes from at least one of the three tissues analyzed, at week 1 (B), week 2 (C), and week 3 (D) postinoculation. All DNA was measured by qPCR in triplicate for spirochete loads, and data are presented as the number of spirochete flaB copies per 1010 mouse nid copies. The mean for each group of data is represented by a horizontal line. Data were compared using one-way ANOVA and Tukey's posttest (GraphPad Prism, version 6.0). Statistical comparisons were not found to be significant unless otherwise noted. Asterisks indicate significant differences (P < 0.05).

DISCUSSION

The nutrient salvage mechanisms that B. burgdorferi uses to survive during mammalian infection remain largely unknown but may represent novel targets for therapeutic intervention for Lyme disease. Using an in vivo expression technology (IVET)-based approach to screen for B. burgdorferi genes expressed during an active murine infection, we previously identified gene bb0318 (28), which is predicted to encode the ATPase component of a putative riboflavin ABC transport system (1, 29). We have now demonstrated that bb0318 contributes to the ability of B. burgdorferi to survive in the presence of oxidative stress and is important for mammalian infection.

Without the ATPase to hydrolyze ATP and drive the activity of the transport system, the functionality of an ABC transporter is either significantly reduced or eliminated (48, 49). By deleting bb0318, the gene encoding the ATPase of a putative riboflavin transport system, we investigated the effects of removing the functionality of the transport system on B. burgdorferi biology both in vitro and in vivo. The bb0318 gene was found to be dispensable for growth under standard in vitro conditions, indicating that the gene does not provide an essential function in nutrient-rich growth medium. The transport system encoded by bb0319 to bb0316 has been proposed to take up riboflavin (29), and riboflavin is the precursor for the synthesis of cofactors FMN and FAD, which are critical for the CoA/CoADR redox system, leading to our hypothesis that bb0318 may contribute to the resistance of B. burgdorferi to oxidative stress. In agreement with this hypothesis, we demonstrated that spirochetes lacking bb0318 had a diminished ability to survive in the presence of high concentrations of H2O2 under microaerobic growth conditions and when challenged with murine macrophages. This phenotype is similar to what has been reported for spirochetes lacking the ROS scavenger superoxide dismutase when they are challenged with both chemical and biological sources of oxidative stress (14).

Previous work examining B. burgdorferi lacking CoADR determined that CoADR plays a role in the oxidative stress response by mediating the CoA/CoASH thiol redox system (11). Although this enzyme was proposed to protect the spirochete against H2O2, the cdr mutant was found not to differ significantly from wild-type B. burgdorferi in sensitivity to H2O2 stress (11, 13). However, this system may not be the only small-thiol redox system in B. burgdorferi; its genome contains genes encoding thioredoxin (trxA; bb0061) and thioredoxin reductase (trxB; bb0515) (9, 13), which may represent an additional active redox system. Because both CoA and thioredoxin reductases use FAD to reduce their respective small thiols (13, 50), the lack of sensitivity of the Δcdr mutant to H2O2 may be due to compensation by the alternative redox system. In contrast, spirochetes lacking bb0318 may be unable to acquire sufficient riboflavin, necessary for FAD synthesis, for the function of both redox systems. Alternatively, our data do not rule out the possibility that bb0318 contributes another, yet-to-be-determined function to B. burgdorferi biology.

A link between riboflavin uptake and oxidative stress resistance has been demonstrated for other bacterial species. Lactococcus lactis exhibits heat-induced sensitivity to oxidative stress from dissolved oxygen in the growth medium and a temperature-dependent decrease in intracellular FAD levels. This phenotype could be rescued by overexpression of a riboflavin transporter, leading to restored FAD biosynthesis and bacterial fitness (51). As B. burgdorferi enters the bloodstream to disseminate to deep tissues, it encounters an oxidative environment due to the dissolved oxygen present in the blood. As with L. lactis, survival under these conditions may depend on the spirochete's ability to salvage riboflavin for sufficient FAD biosynthesis and oxidative stress resistance. Similarly, B. burgdorferi may encounter deleterious reactive oxygen species during the tick stages of the infectious cycle. Indeed, the BosR-regulated putative oxidative stress gene bb0690 (napA; dps) is critical for spirochete persistence in unfed ticks (52), and CoADR contributes to survival in feeding ticks (13). We found that the expression of bb0318, along with that of bb0319, bb0317, and bb0316, was higher in unfed nymphs than in fed nymphs and mouse tissues, suggesting that in addition to the role of bb0318 in the mouse, this gene, and likely genes bb0319 to bb0316, may also contribute to B. burgdorferi survival in the tick.

B. burgdorferi has been shown to undergo a population bottleneck upon inoculation into the mammalian host (53, 54). The innate immune response is critical for controlling B. burgdorferi infection (5558). The magnitude of the spirochete population bottleneck has been shown to be reduced in mice with an impaired innate immune system (54). The oxidative stress that the spirochete encounters during the initial stages of mammalian infection may be due to H2O2 production by innate immune cells, such as macrophages and neutrophils, during the host inflammatory response (9). Our data indicate that B. burgdorferi lacking bb0318 has increased susceptibility to killing by murine macrophages in vitro, suggesting that this mutant may be particularly vulnerable to the bottleneck effect of the host innate immune response early in mammalian infection, resulting in an attenuation in virulence. The 50% infectious dose of the bb0318 mutant was found to be 100-fold higher than that of spirochetes harboring bb0318. The infectivity defect of spirochetes lacking bb0318 is consistent with what has been reported for this gene in both a genomewide signature-tagged mutagenesis study and an analysis of B. burgdorferi genes important for pathogenesis that combined transposon mutagenesis with high-throughput sequencing (Tn-seq) (5961). Because B. burgdorferi lacking bb0318 was able to infect mice at a dose of 1 × 107 spirochetes, we were able to gain insight into the requirement of B. burgdorferi for bb0318 in order to infect mice. At a high-dose inoculum, Δbb0318 spirochetes were defective in their ability to disseminate early during infection; they did not reach wild-type levels of reisolation-positive tissues until 3 weeks postinoculation. Moreover, even at 3 weeks postinoculation, spirochetes were not detected in the heart tissues of mice infected with the Δbb0318 clone. These data suggest that at a high-dose inoculum, the Δbb0318 mutant is able to partially overcome its virulence defect. Despite the increased susceptibility of spirochetes lacking bb0318 to macrophage killing, at the dose of 1 × 107 spirochetes, the Δbb0318 mutant may be able to overwhelm the innate immune system, allowing some fraction of the spirochete population to escape and cause a disseminated infection, though to a lesser extent than wild-type spirochetes. In addition, it is possible that at this dose, the high density of spirochetes offers a protective effect against the innate immune system, resulting from the action of ROS detoxification proteins that do not rely on riboflavin to generate the FAD cofactor, such as the superoxide dismutase activity of SodA (14, 26, 27, 62) and/or additional, yet-to-be-defined BosR-regulated proteins (24). It is noteworthy that although a number of putative mechanisms may compensate for the pathogenesis defects of the Δbb0318 spirochetes, none allowed the mutant to infect the heart tissue, suggesting that this mutant may provide insight into the molecular mechanisms of B. burgdorferi colonization of the heart. Taken together, these findings suggest that the bb0318 gene, and therefore the BB0319-to-BB0316 transport system, may be critical for the ability of B. burgdorferi to resist killing by the oxidative stress conditions produced by innate immune cells and signaling molecules early during infection, as well as for the ability of B. burgdorferi to disseminate to the heart.

In this study, we demonstrated that as the gene encoding the ATPase of a putative transport system, bb0318 is necessary for B. burgdorferi to maintain a wild-type infection in mice, not only with regard to the number of spirochetes required to mount an infection but also with regard to the ability to disseminate effectively. Furthermore, we give evidence that Δbb0318 spirochetes are more susceptible than wild-type or complemented spirochetes to oxidative stress from H2O2, as well as to murine macrophages in vitro. Although much remains to be studied about the interplay of B. burgdorferi nutrient salvage and the oxidative stress response, and its meaning for the pathogen's survival throughout the infectious cycle, this work provides insight into the mechanisms by which the acquisition and use of metabolic precursors may contribute to B. burgdorferi pathogenesis in the mammalian host.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

Thank you to Frank Gherardini and Travis Bourret for insightful comments and suggestions. We are grateful to Kyle Rohde and Sandra Geden for providing the J774 macrophages. We appreciate all the invaluable technical and intellectual contributions of Travis Jewett. Thank you to Carlos Flores Avile for technical assistance. Thank you to the NAF animal care staff. The following reagent was provided by Centers for Disease Control and Prevention for distribution by BEI Resources, NIAID, NIH: Ixodes scapularis Larvae (Live), NR-44115.

Funding Statement

This work was funded by National Research Fund for Tick-Borne Diseases (Pilot Grant 2012-2013 to M.W.J.) and the National Institute of Allergy and Infectious Diseases (NIAID) (R01AI099094 and K22AI081730 to M.W.J.).

Footnotes

Supplemental material for this article may be found at http://dx.doi.org/10.1128/IAI.00430-16.

REFERENCES

  • 1.Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton MD, Horst K, Roberts K, Hatch B, Smith HO, Venter JC. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580–586. doi: 10.1038/37551. [DOI] [PubMed] [Google Scholar]
  • 2.Brisson D, Zhou W, Jutras BL, Casjens S, Stevenson B. 2013. Distribution of cp32 prophages among Lyme disease-causing spirochetes and natural diversity of their lipoprotein-encoding erp loci. Appl Environ Microbiol 79:4115–4128. doi: 10.1128/AEM.00817-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, Haft D, Hickey E, Gwinn M, White O, Fraser CM. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35:490–516. doi: 10.1046/j.1365-2958.2000.01698.x. [DOI] [PubMed] [Google Scholar]
  • 4.Saier MH Jr, Paulsen IT. 2000. Whole genome analyses of transporters in spirochetes: Borrelia burgdorferi and Treponema pallidum. J Mol Microbiol Biotechnol 2:393–399. [PubMed] [Google Scholar]
  • 5.Jain S, Showman AC, Jewett MW. 2015. Molecular dissection of a Borrelia burgdorferi in vivo essential purine transport system. Infect Immun 83:2224–2233. doi: 10.1128/IAI.02859-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jain S, Sutchu S, Rosa PA, Byram R, Jewett MW. 2012. Borrelia burgdorferi harbors a transport system essential for purine salvage and mammalian infection. Infect Immun 80:3086–3093. doi: 10.1128/IAI.00514-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Khajanchi BK, Odeh E, Gao L, Jacobs MB, Philipp MT, Lin T, Norris SJ. 2016. Phosphoenolpyruvate phosphotransferase system components modulate gene transcription and virulence of Borrelia burgdorferi. Infect Immun 84:754–764. doi: 10.1128/IAI.00917-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ouyang Z, He M, Oman T, Yang XF, Norgard MV. 2009. A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi. Proc Natl Acad Sci U S A 106:3449–3454. doi: 10.1073/pnas.0812999106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boylan JA, Gherardini FC. 2008. Determining the cellular targets of reactive oxygen species in Borrelia burgdorferi. Methods Mol Biol 431:213–221. [DOI] [PubMed] [Google Scholar]
  • 10.Posey JE, Gherardini FC. 2000. Lack of a role for iron in the Lyme disease pathogen. Science 288:1651–1653. doi: 10.1126/science.288.5471.1651. [DOI] [PubMed] [Google Scholar]
  • 11.Boylan JA, Hummel CS, Benoit S, Garcia-Lara J, Treglown-Downey J, Crane EJ III, Gherardini FC. 2006. Borrelia burgdorferi bb0728 encodes a coenzyme A disulphide reductase whose function suggests a role in intracellular redox and the oxidative stress response. Mol Microbiol 59:475–486. doi: 10.1111/j.1365-2958.2005.04963.x. [DOI] [PubMed] [Google Scholar]
  • 12.Boylan JA, Posey JE, Gherardini FC. 2003. Borrelia oxidative stress response regulator, BosR: a distinctive Zn-dependent transcriptional activator. Proc Natl Acad Sci U S A 100:11684–11689. doi: 10.1073/pnas.2032956100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Eggers CH, Caimano MJ, Malizia RA, Kariu T, Cusack B, Desrosiers DC, Hazlett KR, Claiborne A, Pal U, Radolf JD. 2011. The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host. Mol Microbiol 82:679–697. doi: 10.1111/j.1365-2958.2011.07845.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Esteve-Gassent MD, Elliott NL, Seshu J. 2009. sodA is essential for virulence of Borrelia burgdorferi in the murine model of Lyme disease. Mol Microbiol 71:594–612. doi: 10.1111/j.1365-2958.2008.06549.x. [DOI] [PubMed] [Google Scholar]
  • 15.Narasimhan S, Sukumaran B, Bozdogan U, Thomas V, Liang X, DePonte K, Marcantonio N, Koski RA, Anderson JF, Kantor F, Fikrig E. 2007. A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector. Cell Host Microbe 2:7–18. doi: 10.1016/j.chom.2007.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Seshu J, Boylan JA, Gherardini FC, Skare JT. 2004. Dissolved oxygen levels alter gene expression and antigen profiles in Borrelia burgdorferi. Infect Immun 72:1580–1586. doi: 10.1128/IAI.72.3.1580-1586.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Seshu J, Boylan JA, Hyde JA, Swingle KL, Gherardini FC, Skare JT. 2004. A conservative amino acid change alters the function of BosR, the redox regulator of Borrelia burgdorferi. Mol Microbiol 54:1352–1363. doi: 10.1111/j.1365-2958.2004.04352.x. [DOI] [PubMed] [Google Scholar]
  • 18.Katona LI. 2015. The Fur homologue BosR requires Arg39 to activate rpoS transcription in Borrelia burgdorferi and thereby direct spirochaete infection in mice. Microbiology 161:2243–2255. doi: 10.1099/mic.0.000166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ouyang Z, Deka RK, Norgard MV. 2011. BosR (BB0647) controls the RpoN-RpoS regulatory pathway and virulence expression in Borrelia burgdorferi by a novel DNA-binding mechanism. PLoS Pathog 7:e1001272. doi: 10.1371/journal.ppat.1001272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ouyang Z, Kumar M, Kariu T, Haq S, Goldberg M, Pal U, Norgard MV. 2009. BosR (BB0647) governs virulence expression in Borrelia burgdorferi. Mol Microbiol 74:1331–1343. doi: 10.1111/j.1365-2958.2009.06945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ouyang Z, Zhou J, Norgard MV. 2016. Evidence that BosR (BB0647) is a positive autoregulator in Borrelia burgdorferi. Infect Immun 84:2566–2574. doi: 10.1128/IAI.00297-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shi Y, Dadhwal P, Li X, Liang FT. 2014. BosR functions as a repressor of the ospAB operon in Borrelia burgdorferi. PLoS One 9:e109307. doi: 10.1371/journal.pone.0109307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang P, Dadhwal P, Cheng Z, Zianni MR, Rikihisa Y, Liang FT, Li X. 2013. Borrelia burgdorferi oxidative stress regulator BosR directly represses lipoproteins primarily expressed in the tick during mammalian infection. Mol Microbiol 89:1140–1153. doi: 10.1111/mmi.12337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hyde JA, Seshu J, Skare JT. 2006. Transcriptional profiling of Borrelia burgdorferi containing a unique bosR allele identifies a putative oxidative stress regulon. Microbiology 152:2599–2609. doi: 10.1099/mic.0.28996-0. [DOI] [PubMed] [Google Scholar]
  • 25.Hyde JA, Shaw DK, Smith R III, Trzeciakowski JP, Skare JT. 2009. The BosR regulatory protein of Borrelia burgdorferi interfaces with the RpoS regulatory pathway and modulates both the oxidative stress response and pathogenic properties of the Lyme disease spirochete. Mol Microbiol 74:1344–1355. doi: 10.1111/j.1365-2958.2009.06951.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Troxell B, Xu H, Yang XF. 2012. Borrelia burgdorferi, a pathogen that lacks iron, encodes manganese-dependent superoxide dismutase essential for resistance to streptonigrin. J Biol Chem 287:19284–19293. doi: 10.1074/jbc.M112.344903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Esteve-Gassent MD, Smith TC II, Small CM, Thomas DP, Seshu J. 2015. Absence of sodA increases the levels of oxidation of key metabolic determinants of Borrelia burgdorferi. PLoS One 10:e0136707. doi: 10.1371/journal.pone.0136707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ellis TC, Jain S, Linowski AK, Rike K, Bestor A, Rosa PA, Halpern M, Kurhanewicz S, Jewett MW. 2013. In vivo expression technology identifies a novel virulence factor critical for Borrelia burgdorferi persistence in mice. PLoS Pathog 9:e1003567. doi: 10.1371/journal.ppat.1003567 (Erratum, 10: e1004260, 2014, doi:.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Deka RK, Brautigam CA, Biddy BA, Liu WZ, Norgard MV. 2013. Evidence for an ABC-type riboflavin transporter system in pathogenic spirochetes. mBio 4(1):e00615-12. doi: 10.1128/mBio.00615-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Dam P, Olman V, Harris K, Su Z, Xu Y. 2007. Operon prediction using both genome-specific and general genomic information. Nucleic Acids Res 35:288–298. doi: 10.1093/nar/gkl1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mao F, Dam P, Chou J, Olman V, Xu Y. 2009. DOOR: a database for prokaryotic operons. Nucleic Acids Res 37:D459–D463. doi: 10.1093/nar/gkn757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Serrano A, Ferreira P, Martinez-Julvez M, Medina M. 2013. The prokaryotic FAD synthetase family: a potential drug target. Curr Pharm Des 19:2637–2648. doi: 10.2174/1381612811319140013. [DOI] [PubMed] [Google Scholar]
  • 33.Gherardini F, Boylan J, Lawrence K, Skare J. 2010. Metabolism and physiology of Borrelia, p 103–138. In Samuels DS, Radolf JD (ed), Borrelia: molecular biology, host interaction and pathogenesis. Caister Academic Press, Norfolk, United Kingdom. [Google Scholar]
  • 34.Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, Geer RC, He J, Gwadz M, Hurwitz DI, Lanczycki CJ, Lu F, Marchler GH, Song JS, Thanki N, Wang Z, Yamashita RA, Zhang D, Zheng C, Bryant SH. 2015. CDD: NCBI's conserved domain database. Nucleic Acids Res 43:D222–D226. doi: 10.1093/nar/gku1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rego RO, Bestor A, Rosa PA. 2011. Defining the plasmid-borne restriction-modification systems of the Lyme disease spirochete Borrelia burgdorferi. J Bacteriol 193:1161–1171. doi: 10.1128/JB.01176-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rosa PA, Hogan D. 1992. Colony formation by Borrelia burgdorferi in solid medium: clonal analysis of osp locus variants, p 95–103. In Munderloh UG, Kurtti TJ (ed), First International Conference on Tick Borne Pathogens at the Host-Vector Interface; an agenda for research: proceedings and abstracts, September 15–18, 1992. University of Minnesota, St. Paul, MN. [Google Scholar]
  • 37.Samuels DS. 1995. Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol Biol 47:253–259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Jewett MW, Lawrence K, Bestor AC, Tilly K, Grimm D, Shaw P, VanRaden M, Gherardini F, Rosa PA. 2007. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol Microbiol 64:1358–1374. doi: 10.1111/j.1365-2958.2007.05746.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Elias AF, Stewart PE, Grimm D, Caimano MJ, Eggers CH, Tilly K, Bono JL, Akins DR, Radolf JD, Schwan TG, Rosa P. 2002. Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect Immun 70:2139–2150. doi: 10.1128/IAI.70.4.2139-2150.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Elias AF, Bono JL, Kupko JJ III, Stewart PE, Krum JG, Rosa PA. 2003. New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi. J Mol Microbiol Biotechnol 6:29–40. doi: 10.1159/000073406. [DOI] [PubMed] [Google Scholar]
  • 41.Drecktrah D, Lybecker M, Popitsch N, Rescheneder P, Hall LS, Samuels DS. 2015. The Borrelia burgdorferi RelA/SpoT homolog and stringent response regulate survival in the tick vector and global gene expression during starvation. PLoS Pathog 11:e1005160. doi: 10.1371/journal.ppat.1005160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Troxell B, Zhang JJ, Bourret TJ, Zeng MY, Blum J, Gherardini F, Hassan HM, Yang XF. 2014. Pyruvate protects pathogenic spirochetes from H2O2 killing. PLoS One 9:e84625. doi: 10.1371/journal.pone.0084625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Jewett MW, Lawrence KA, Bestor A, Byram R, Gherardini F, Rosa PA. 2009. GuaA and GuaB are essential for Borrelia burgdorferi survival in the tick-mouse infection cycle. J Bacteriol 191:6231–6241. doi: 10.1128/JB.00450-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Jewett MW, Byram R, Bestor A, Tilly K, Lawrence K, Burtnick MN, Gherardini F, Rosa PA. 2007. Genetic basis for retention of a critical virulence plasmid of Borrelia burgdorferi. Mol Microbiol 66:975–990. doi: 10.1111/j.1365-2958.2007.05969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Modolell M, Schaible UE, Rittig M, Simon MM. 1994. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol Lett 40:139–146. doi: 10.1016/0165-2478(94)90185-6. [DOI] [PubMed] [Google Scholar]
  • 46.Bestor A, Rego RO, Tilly K, Rosa PA. 2012. Competitive advantage of Borrelia burgdorferi with outer surface protein BBA03 during tick-mediated infection of the mammalian host. Infect Immun 80:3501–3511. doi: 10.1128/IAI.00521-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Moon KH, Hobbs G, Motaleb MA. 2016. Borrelia burgdorferi CheD promotes various functions in chemotaxis and the pathogenic life cycle of the spirochete. Infect Immun 84:1743–1752. doi: 10.1128/IAI.01347-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Davidson AL, Sharma S. 1997. Mutation of a single MalK subunit severely impairs maltose transport activity in Escherichia coli. J Bacteriol 179:5458–5464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Liu CE, Liu PQ, Ames GF. 1997. Characterization of the adenosine triphosphatase activity of the periplasmic histidine permease, a traffic ATPase (ABC transporter). J Biol Chem 272:21883–21891. doi: 10.1074/jbc.272.35.21883. [DOI] [PubMed] [Google Scholar]
  • 50.Lu J, Holmgren A. 2014. The thioredoxin antioxidant system. Free Radic Biol Med 66:75–87. doi: 10.1016/j.freeradbiomed.2013.07.036. [DOI] [PubMed] [Google Scholar]
  • 51.Chen J, Shen J, Solem C, Jensen PR. 2013. Oxidative stress at high temperatures in Lactococcus lactis due to an insufficient supply of riboflavin. Appl Environ Microbiol 79:6140–6147. doi: 10.1128/AEM.01953-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Li X, Pal U, Ramamoorthi N, Liu X, Desrosiers DC, Eggers CH, Anderson JF, Radolf JD, Fikrig E. 2007. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 63:694–710. doi: 10.1111/j.1365-2958.2006.05550.x. [DOI] [PubMed] [Google Scholar]
  • 53.Rego RO, Bestor A, Stefka J, Rosa PA. 2014. Population bottlenecks during the infectious cycle of the Lyme disease spirochete Borrelia burgdorferi. PLoS One 9:e101009. doi: 10.1371/journal.pone.0101009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Troy EB, Lin T, Gao L, Lazinski DW, Camilli A, Norris SJ, Hu L. 2013. Understanding barriers to Borrelia burgdorferi dissemination during infection using massively parallel sequencing. Infect Immun 81:2347–2357. doi: 10.1128/IAI.00266-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Bockenstedt LK, Liu N, Schwartz I, Fish D. 2006. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks. Infect Immun 74:2154–2160. doi: 10.1128/IAI.74.4.2154-2160.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ, Zachary JF, Weis JH, Weis JJ. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173:2003–2010. doi: 10.4049/jimmunol.173.3.2003. [DOI] [PubMed] [Google Scholar]
  • 57.Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72:3195–3203. doi: 10.1128/IAI.72.6.3195-3203.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Petnicki-Ocwieja T, Kern A. 2014. Mechanisms of Borrelia burgdorferi internalization and intracellular innate immune signaling. Front Cell Infect Microbiol 4:175. doi: 10.3389/fcimb.2014.00175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Lin T, Gao L, Zhang C, Odeh E, Jacobs MB, Coutte L, Chaconas G, Philipp MT, Norris SJ. 2012. Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS One 7:e47532. doi: 10.1371/journal.pone.0047532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lin T, Troy EB, Hu LT, Gao L, Norris SJ. 2014. Transposon mutagenesis as an approach to improved understanding of Borrelia pathogenesis and biology. Front Cell Infect Microbiol 4:63. doi: 10.3389/fcimb.2014.00063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Troy EB, Lin T, Gao L, Lazinski DW, Lundt M, Camilli A, Norris SJ, Hu LT. 9 June 2016. Global Tn-seq analysis of carbohydrate utilization and vertebrate infectivity of Borrelia burgdorferi. Mol Microbiol. doi: 10.1111/mmi.13437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Aguirre JD, Clark HM, McIlvin M, Vazquez C, Palmere SL, Grab DJ, Seshu J, Hart PJ, Saito M, Culotta VC. 2013. A manganese-rich environment supports superoxide dismutase activity in a Lyme disease pathogen, Borrelia burgdorferi. J Biol Chem 288:8468–8478. doi: 10.1074/jbc.M112.433540. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES